AptarGroup ATR Pharma — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AptarGroup in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about AptarGroup's pharma — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AptarGroup's pharma — capex?
- AptarGroup (ATR) reported pharma — capex of $28.89M in Q1 2026.
- How has AptarGroup's pharma — capex changed year-over-year?
- AptarGroup's pharma — capex decreased by 1.9% year-over-year, from $29.45M to $28.89M.
- What does pharma — capex mean?
- Funds used by the pharma segment to acquire, upgrade, and maintain physical assets such as property, plants, and equipment. This reflects the company's commitment to expanding capacity or improving manufacturing technology.